TY  - JOUR
A1  - Engel, Katharina
A1  - Rudelius, Martina
A1  - Slawska, Jolanta
A1  - Jacobs, Laura
A1  - Abhari, Behnaz Ahangarian
A1  - Altmann, Bettina
A1  - Kurutz, Julia
A1  - Rathakrishnan, Abirami
A1  - Fernández-Sáiz, Vanesa
A1  - Brunner, Andrä
A1  - Targosz, Bianca-Sabrina
A1  - Loewecke, Felicia
A1  - Gloeckner, Christian Johannes
A1  - Ueffing, Marius
A1  - Fulda, Simone
A1  - Pfreundschuh, Michael
A1  - Trümper, Lorenz
A1  - Klapper, Wolfram
A1  - Keller, Ulrich
A1  - Jost, Philipp J.
A1  - Rosenwald, Andreas
A1  - Peschel, Christian
A1  - Bassermann, Florian
T1  - USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma
JF  - EMBO Molecular Medicine
N2  - The mitotic spindle assembly checkpoint (SAC) maintains genome stability and marks an important target for antineoplastic therapies. However, it has remained unclear how cells execute cell fate decisions under conditions of SAC‐induced mitotic arrest. Here, we identify USP9X as the mitotic deubiquitinase of the X‐linked inhibitor of apoptosis protein (XIAP) and demonstrate that deubiquitylation and stabilization of XIAP by USP9X lead to increased resistance toward mitotic spindle poisons. We find that primary human aggressive B‐cell lymphoma samples exhibit high USP9X expression that correlate with XIAP overexpression. We show that high USP9X/XIAP expression is associated with shorter event‐free survival in patients treated with spindle poison‐containing chemotherapy. Accordingly, aggressive B‐cell lymphoma lines with USP9X and associated XIAP overexpression exhibit increased chemoresistance, reversed by specific inhibition of either USP9X or XIAP. Moreover, knockdown of USP9X or XIAP significantly delays lymphoma development and increases sensitivity to spindle poisons in a murine Eμ‐Myc lymphoma model. Together, we specify the USP9X–XIAP axis as a regulator of the mitotic cell fate decision and propose that USP9X and XIAP are potential prognostic biomarkers and therapeutic targets in aggressive B‐cell lymphoma.
KW  - B‐cell lymphoma
KW  - mitosis
KW  - ubiquitin
KW  - USP9X
KW  - XIAP
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-165016
VL  - 8
ER  - 
TY  - JOUR
A1  - Schmalzl, Jonas
A1  - Plumhoff, Piet
A1  - Gilbert, Fabian
A1  - Gohlke, Frank
A1  - Konrads, Christian
A1  - Brunner, Ulrich
A1  - Jakob, Franz
A1  - Ebert, Regina
A1  - Steinert, Andre F.
T1  - Tendon-derived stem cells from the long head of the biceps tendon
JF  - Bone & Joint Research
N2  - Objectives
The long head of the biceps (LHB) is often resected in shoulder surgery and could therefore serve as a cell source for tissue engineering approaches in the shoulder. However, whether it represents a suitable cell source for regenerative approaches, both in the inflamed and non-inflamed states, remains unclear. In the present study, inflamed and native human LHBs were comparatively characterized for features of regeneration.

Methods
In total, 22 resected LHB tendons were classified into inflamed samples (n = 11) and non-inflamed samples (n = 11). Proliferation potential and specific marker gene expression of primary LHB-derived cell cultures were analyzed. Multipotentiality, including osteogenic, adipogenic, chondrogenic, and tenogenic differentiation potential of both groups were compared under respective lineage-specific culture conditions.

Results
Inflammation does not seem to affect the proliferation rate of the isolated tendon-derived stem cells (TDSCs) and the tenogenic marker gene expression. Cells from both groups showed an equivalent osteogenic, adipogenic, chondrogenic and tenogenic differentiation potential in histology and real-time polymerase chain reaction (RT-PCR) analysis.

Conclusion
These results suggest that the LHB tendon might be a suitable cell source for regenerative approaches, both in inflamed and non-inflamed states. The LHB with and without tendinitis has been characterized as a novel source of TDSCs, which might facilitate treatment of degeneration and induction of regeneration in shoulder surgery.
KW  - biceps tendon
KW  - tendon-derived stem cell
KW  - mesenchymal stem cell
KW  - tissue engineering
KW  - shoulder
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-200370
VL  - 8
IS  - 9
ER  -